160 related articles for article (PubMed ID: 35002325)
21. [Prognostic values of spindle checkpoint protein BUB1B in triple negative breast cancer].
Zhang PC; Zhong XR; Zheng H; Li L; Chen F; Shen MJ; Li YJ; Chen H; Cao SY; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):645-649. PubMed ID: 34078054
[No Abstract] [Full Text] [Related]
22. Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.
Wang Y; Li H; Ma J; Fang T; Li X; Liu J; Afewerky HK; Li X; Gao Q
Onco Targets Ther; 2019; 12():8401-8410. PubMed ID: 31632087
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis of human kallikrein 5 (
Song Y; Bai G; Li X; Zhou L; Si Y; Liu X; Deng Y; Shi Y
Cancer Innov; 2023 Oct; 2(5):376-390. PubMed ID: 38090381
[TBL] [Abstract][Full Text] [Related]
24. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
[TBL] [Abstract][Full Text] [Related]
25. HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration.
Ying B; Xu W; Nie Y; Li Y
Dis Markers; 2022; 2022():8446857. PubMed ID: 36452344
[TBL] [Abstract][Full Text] [Related]
26. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1.
Ren Y; Deng R; Zhang Q; Li J; Han B; Ye P
Ann Transl Med; 2020 Dec; 8(24):1637. PubMed ID: 33490149
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel prognostic genes of triple-negative breast cancer using meta-analysis and weighted gene co-expressed network analysis.
Cao W; Jiang Y; Ji X; Guan X; Lin Q; Ma L
Ann Transl Med; 2021 Feb; 9(3):205. PubMed ID: 33708832
[TBL] [Abstract][Full Text] [Related]
29. Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis.
Yang B; Zhang M; Luo T
Front Genet; 2020; 11():517362. PubMed ID: 33193601
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer.
Li Y; Yang S; Qi L; Li Y; Wang X
Adv Ther; 2024 Apr; 41(4):1621-1636. PubMed ID: 38421558
[TBL] [Abstract][Full Text] [Related]
31. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
[TBL] [Abstract][Full Text] [Related]
32. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis.
Lin Z; Peng R; Sun Y; Zhang L; Zhang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305312
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer.
Ma X; Liu H; Shi C; Zhao Y; Wang H; Han Z
Heliyon; 2024 Mar; 10(5):e27368. PubMed ID: 38495206
[TBL] [Abstract][Full Text] [Related]
34. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
35. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.
Zhai X; Yang Z; Liu X; Dong Z; Zhou D
PeerJ; 2020; 8():e9975. PubMed ID: 33005492
[TBL] [Abstract][Full Text] [Related]
36. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
37. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
38. Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells
Wu S; Su R; Jia H
Dis Markers; 2021; 2021():5511041. PubMed ID: 34354775
[TBL] [Abstract][Full Text] [Related]
39. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
[TBL] [Abstract][Full Text] [Related]
40. Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.
Wei LM; Li XY; Wang ZM; Wang YK; Yao G; Fan JH; Wang XS
Gland Surg; 2021 Feb; 10(2):799-806. PubMed ID: 33708561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
